Jori E Fleisher1, Meghan M Sweeney1, Sarah Oyler1, Talia Meisel1, Naomi Friede1, Alessandro Di Rocco1, Joshua Chodosh1. 1. Rush University (JEF), Section of Movement Disorders, Department of Neurological Sciences, Chicago, IL; New York University Langone Health (JEF), Marlene and Paolo Fresco Institute for Parkinson's and Movement Disorders, Department of Neurology, NY; Kaiser Permanente (MMS), Department of Palliative Care, Lafayette, CO; Intermountain Medical Center (SO), Movement Disorders, Murray, UT; SUNY Downstate Medical Center College of Medicine (TM), Brooklyn, NY; Yale School of Nursing (NF), Orange, CT; Northwell Health and Donald and Barbara Zucker School of Medicine at Hofstra/Northwell (ADR), Long Island, NY; New York University School of Medicine (JC), Division of Geriatric Medicine and Palliative Care, Department of Medicine, New York, NY; and VA New York Harbor Healthcare System (JC), Medicine Service, New York, NY.
Abstract
BACKGROUND: As Parkinson disease (PD) progresses, symptoms increase, quality of life (QoL) declines, and individuals may become homebound, often losing access to neurologic care. We aimed to determine whether facilitating expert in-home care could improve our understanding of disease progression, treatment options, and unmet needs in this vulnerable population, and whether such a model could mitigate decline in QoL. METHODS: Patients with PD meeting Medicare homebound criteria were eligible for quarterly interdisciplinary home visits over 12 months. Each visit entailed an evaluation by a movement disorders neurologist, social worker, and nurse, including history, examination, medication reconciliation, psychosocial evaluation, pharmacologic and nonpharmacologic management, and service referrals. Disease severity, as measured by the Unified Parkinson's Disease Rating Scale (UPDRS), and QoL using the Neuro-QoL were measured at visits 1 and 4. RESULTS: Of 27 enrolled patients, 23 completed 4 visits, with high retention and high patient- and caregiver-reported satisfaction. The mean age at baseline was 80.9 years (SD 7.8) with a mean total UPDRS of 65.0 (SD 20.0). After one year of home visits, total UPDRS worsened by a mean of 11.8 points (p < 0.01) without a change in any of 8 QoL domains (p = 0.19-0.95). CONCLUSIONS: Homebound individuals with advanced PD receiving interdisciplinary home visits experienced no significant decline in QoL over 1 year, despite disease progression. Our findings highlight the disease severity and impaired QoL of the advanced, homebound PD population, and the potential for novel approaches to foster continuity of care.
BACKGROUND: As Parkinson disease (PD) progresses, symptoms increase, quality of life (QoL) declines, and individuals may become homebound, often losing access to neurologic care. We aimed to determine whether facilitating expert in-home care could improve our understanding of disease progression, treatment options, and unmet needs in this vulnerable population, and whether such a model could mitigate decline in QoL. METHODS: Patients with PD meeting Medicare homebound criteria were eligible for quarterly interdisciplinary home visits over 12 months. Each visit entailed an evaluation by a movement disorders neurologist, social worker, and nurse, including history, examination, medication reconciliation, psychosocial evaluation, pharmacologic and nonpharmacologic management, and service referrals. Disease severity, as measured by the Unified Parkinson's Disease Rating Scale (UPDRS), and QoL using the Neuro-QoL were measured at visits 1 and 4. RESULTS: Of 27 enrolled patients, 23 completed 4 visits, with high retention and high patient- and caregiver-reported satisfaction. The mean age at baseline was 80.9 years (SD 7.8) with a mean total UPDRS of 65.0 (SD 20.0). After one year of home visits, total UPDRS worsened by a mean of 11.8 points (p < 0.01) without a change in any of 8 QoL domains (p = 0.19-0.95). CONCLUSIONS: Homebound individuals with advanced PD receiving interdisciplinary home visits experienced no significant decline in QoL over 1 year, despite disease progression. Our findings highlight the disease severity and impaired QoL of the advanced, homebound PD population, and the potential for novel approaches to foster continuity of care.
Authors: Paul A Harris; Robert Taylor; Robert Thielke; Jonathon Payne; Nathaniel Gonzalez; Jose G Conde Journal: J Biomed Inform Date: 2008-09-30 Impact factor: 6.317
Authors: Chad Boult; Ariel Frank Green; Lisa B Boult; James T Pacala; Claire Snyder; Bruce Leff Journal: J Am Geriatr Soc Date: 2009-12 Impact factor: 5.562
Authors: D Cella; J-S Lai; C J Nowinski; D Victorson; A Peterman; D Miller; F Bethoux; A Heinemann; S Rubin; J E Cavazos; A T Reder; R Sufit; T Simuni; G L Holmes; A Siderowf; V Wojna; R Bode; N McKinney; T Podrabsky; K Wortman; S Choi; R Gershon; N Rothrock; C Moy Journal: Neurology Date: 2012-05-09 Impact factor: 9.910
Authors: Noelle E Carlozzi; David Victorson; Victor Sung; Jennifer L Beaumont; Wendy Cheng; Brian Gorin; Mei Sheng Duh; David Samuelson; David Tulsky; Sandra Gutierrez; Cindy J Nowinski; Allison Mueller; Vivienne Shen; Samuel Frank Journal: Tremor Other Hyperkinet Mov (N Y) Date: 2014-04-14